Pulmonary Hypertension Roundtable: The Role of Exercise in Clinical Practice and Clinical Trials

On May 20, 2019, Guest Editor Ronald Oudiz, MD, Director of the Pulmonary Hypertension Program at Harbor-UCLA Medical Center in Los Angeles, California, led a discussion with Aaron Waxman, MD, PhD, Director of the Center for Pulmonary Heart Disease at Brigham and Women's Hospital and Harvard Medical School in Boston, Massachusetts, and Robert Naeije, MD, Professor Emeritus at the Free University of Brussels, Belgium.

Download Full-text

Roundtable: Other Rare Disorders Associated with Pulmonary Hypertension

Advances in Pulmonary Hypertension ◽

10.21693/1933-088x-14.3.161 ◽

2015 ◽

Vol 14 (3) ◽

pp. 161-165

Keyword(s):

Pulmonary Hypertension ◽

Medical School ◽

Guest Editor ◽

Harvard Medical School ◽

Medical Center ◽

Rare Disorders ◽

University Of Texas ◽

School Of Medicine ◽

University Of Cincinnati ◽

Washington University

While pulmonary hypertension itself is a rare disorder, its association has been identified in conjunction with other rare disorders, which is the theme of this issue of Advances in Pulmonary Hypertension. Co-guest editor Sonja Bartolome, MD, facilitated a discussion regarding the experiences and perceptions of leading PH experts—many authors in this issue—on this topic. Participating were co-guest editor Kelly Chin, MD, University of Texas Southwestern Medical Center; Murali Chakinala, MD, Washington University School of Medicine; Richard Channick, MD, Harvard Medical School; Jean Elwing, MD, University of Cincinnati Medical Center; and adding to the comments later, Robert Baughman, MD, University of Cincinnati. Their conversation follows.

Download Full-text

Roundtable: Pulmonary Hypertension Due to Left Heart Disease

Advances in Pulmonary Hypertension ◽

10.21693/1933-088x-14.2.105 ◽

2015 ◽

Vol 14 (2) ◽

pp. 105-110

Keyword(s):

Pulmonary Hypertension ◽

Heart Disease ◽

Guest Editor ◽

Mayo Clinic ◽

Diagnosis And Treatment ◽

Left Heart ◽

Health Network ◽

University Of Utah ◽

School Of Medicine ◽

Left Heart Disease

Guest editor Teresa De Marco, MD, along with Brian Shapiro, MD, Mayo Clinic, Jacksonville, FL, convened a panel of experts to discuss the challenges in diagnosis and treatment and the emerging science regarding pulmonary hypertension due to left heart disease. Contributing to the engaging discussion were James Fang, MD, University of Utah School of Medicine; Barry Borlaug, MD, Mayo Clinic, Rochester, MN; and Srinivas Murali, MD, Allegheny Health Network, Pittsburgh, PA.

Download Full-text

Pediatric Cardiology

PEDIATRICS ◽

10.1542/peds.21.1.165 ◽

1958 ◽

Vol 21 (1) ◽

pp. 165-165

Author(s):

PAUL R. LURIE

Keyword(s):

Congenital Heart Disease ◽

Heart Disease ◽

Rheumatic Fever ◽

Harvard Medical School ◽

Congenital Heart ◽

Pediatric Cardiology ◽

Heart Diseases ◽

Medical Center ◽

Rapid Development ◽

Laboratory Diagnosis

Many books on rheumatic fever, congenital heart disease, laboratory diagnosis of heart diseases, and lengthy sections on cardiologic subjects in pediatric textbooks have been written but until now there is no comprehensive textbook in the field of pediatric cardiology. It is fortunate that the first book to appear to fill this real need is an excellent one. Dr. Nadas, of the Children's Medical Center in Boston and Harvard Medical School, is a recognized authority in the field of cardiology and has contributed much to its recent rapid development.

Download Full-text

Transfusion Policies and Clinical Practice in a Tertiary Academic Medical Center: Role of Protocols and Documentation

Trigger Factors in Transfusion Medicine ◽

10.1007/978-1-4613-1287-1_13 ◽

1996 ◽

pp. 143-160

Author(s):

M. Petrides ◽

E. L. Snyder

Keyword(s):

Clinical Practice ◽

Medical Center ◽

Academic Medical Center ◽

Academic Medical

Download Full-text

Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: role of the pre-capillary component

10.1183/1393003.congress-2017.pa3525 ◽

2017 ◽

Author(s):

Sergio Caravita ◽

Andrea Faini ◽

Antoine Bondue ◽

Robert Naeije ◽

Gianfranco Parati ◽

...

Keyword(s):

Pulmonary Hypertension ◽

Heart Disease ◽

Left Heart ◽

Clinical Phenotypes ◽

Left Heart Disease

Download Full-text

Right heart catheterisation: best practice and pitfalls in pulmonary hypertension

European Respiratory Review ◽

10.1183/16000617.0062-2015 ◽

2015 ◽

Vol 24 (138) ◽

pp. 642-652 ◽

Cited By ~ 51

Author(s):

Stephan Rosenkranz ◽

Ioana R. Preston

Keyword(s):

Pulmonary Hypertension ◽

Clinical Practice ◽

Best Practice ◽

Data Interpretation ◽

Volume Measurement ◽

Right Heart ◽

Heart Catheterisation ◽

Right Heart Catheterisation ◽

Pulmonary Arterial

Right heart catheterisation (RHC) plays a central role in identifying pulmonary hypertension (PH) disorders, and is required to definitively diagnose pulmonary arterial hypertension (PAH). Despite widespread acceptance, there is a lack of guidance regarding the best practice for performing RHC in clinical practice. In order to ensure the correct evaluation of haemodynamic parameters directly measured or calculated from RHC, attention should be drawn to standardising procedures such as the position of the pressure transducer and catheter balloon inflation volume. Measurement of pulmonary arterial wedge pressure, in particular, is vulnerable to over- or under-wedging, which can give rise to false readings. In turn, errors in RHC measurement and data interpretation can complicate the differentiation of PAH from other PH disorders and lead to misdiagnosis. In addition to diagnosis, the role of RHC in conjunction with noninvasive tests is widening rapidly to encompass monitoring of treatment response and establishing prognosis of patients diagnosed with PAH. However, further standardisation of RHC is warranted to ensure optimal use in routine clinical practice.

Download Full-text

Radiologic Examination of the Small IntestineRadiologic Examination of the Small Intestine. By GoldenRoss, M.D., Visiting Professor of Radiology, University of California at Los Angeles; Professor Emeritus of Radiology, Columbia University; formerly, Director of Radiology, The Columbia-Presbyterian Medical Center, New York City. A volume of 560pages. with 176 figures. Published by Charles C Thomas, Springfield, Ill., 2d ed., 1959. Price $28.50.

Radiology ◽

10.1148/76.1.132a ◽

1961 ◽

Vol 76 (1) ◽

pp. 132-132

Keyword(s):

New York ◽

New York City ◽

Small Intestine ◽

Los Angeles ◽

York City ◽

Medical Center ◽

University Of California ◽

Professor Emeritus ◽

Columbia University ◽

Radiologic Examination

Download Full-text

Drug Treatment in the Prevention of Coronary Artery Disease

10.1055/s-0039-1684684 ◽

1979 ◽

Author(s):

J.R.A. Mitchell

Keyword(s):

Coronary Artery Disease ◽

Coronary Heart Disease ◽

Clinical Trials ◽

Heart Disease ◽

Major Part ◽

Large Scale ◽

End Points ◽

Pump Failure ◽

Artery Disease

The disappointing performance of anticoagulants in the prophylaxis of coronary heart disease led to the realisation that components other than fibrin play a major part in the structure of arterial thrombi. Attention has therefore been focussed on the possible role of agents which modify platelet behaviour. Novel agents which alter thromboxane synthesis will not be available for large-scale clinical trials for some years, so the present trials are assessing the value of platelet-modifying agents which are already in use for other purposes. The implications of the Antura-Reinfarction study and the role of aspirin and persantin will be discussed.Attention will also be drawn to the importance of using valid end-points to assess potential anti-thrombotic regimes in coronary disease. The differential implications of using infarction, sudden death, pump failure, dysrhythmias and re-infarction as end-points in trials will be described.

Download Full-text